Study Stopped
Poor patient enrollment from clinic secondary to investigator illness.
Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
AS-BNP
Utility of Exercise-induced NT-pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
1 other identifier
interventional
110
1 country
1
Brief Summary
One hundred patients with moderate to severe asymptomatic aortic stenosis (AS) will be asked to exercise on a treadmill. NT-pro-BNP levels will be drawn before and after exercise. Changes in NT-pro-BNP levels will be correlated to outcomes at one year. In the pilot phase an additional 10 control subjects without AS will be enrolled to document the control response of NT-pro-BNP elevations with exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
December 4, 2007
CompletedFirst Posted
Study publicly available on registry
December 5, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedOctober 24, 2012
November 1, 2008
December 4, 2007
October 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
development of symptomatic aortic stenosis (new/progressive angina or dyspnea, pre-syncope/syncope, hospitalization for cardiac chest pain or heart failure, drop in LV ejection fraction, cardiovascular or sudden death, valve replacement surgery)
one year
Study Arms (2)
A
OTHER10 patients with no aortic stenosis
B
OTHER100 patients with asymptomatic AS
Interventions
Eligibility Criteria
You may qualify if:
- valvular AS (Doppler velocity ≥ 3.0 m/s)
- no baseline symptoms referable to valvular heart disease
- able to perform ETT
You may not qualify if:
- more than mild aortic regurgitation, mitral regurgitation/ stenosis, or tricuspid regurgitation/stenosis
- previous AVR
- known coronary artery disease
- creatinine clearance 50 mL/min
- LVEF \< 50%
- planned valve surgery prior to enrollment
- significant pulmonary disease
- unable to give informed consent
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27710, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas M. Bashore, MD
Duke University
- PRINCIPAL INVESTIGATOR
John K. Harrison, MD
Duke University
- STUDY DIRECTOR
Aslan T. Turer, MD
Duke University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2007
First Posted
December 5, 2007
Study Start
December 1, 2007
Study Completion
December 1, 2008
Last Updated
October 24, 2012
Record last verified: 2008-11